Supporting the innovators of today for the patient benefit of tomorrow

CARMA FUND I is an early-stage investment fund for advancing the translation of Life Science and Healthcare assets. The fund started off with a First Closing of over €47M in June 2022. It is base in Munich and Frankfurt am Main.

About

CARMA FUND I is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off with a First Closing in June 2022 and has €50M under management. It is based in Munich and Frankfurt am Main.

Our approach

Approach

CARMA FUND I is uniquely suited for young companies and projects from the Life Science and medical space due to an extra-long term, flexible investment modes and its close relationships with leading technology transfer offices and industry partners. 

Starting to develop new products and services for the patients’ well-being and medical advancements comes with its unique challenges and opportunities. Biotech/healthcare is a specialist business and as such innovators have often struggled to rope in reliant streams of outside capital necessary for quick and efficient development towards a market entry.

CARMA FUND I believes in supporting these projects to bring out their full potential. CARMA FUND I welcomes applications for funding from all European sources.

Portfolio

Want to work together?

Contact us

Team

CARMA FUND I’s general partner CARMA FUND Management GmbH is headed by the Managing Partners Christian Leikert and Dr. Martin Raditsch.

50M+

Investment capital

2022

Vintage year

15y+

Term

Join the team

CARMA FUND Management GmbH is looking for new team members to support our vision and mission. To apply, please send your CV and motivation letter using the link below.

INVESTMENT PROFESSIONAL (m/f/d)

Industries we invest in

CARMA FUND is investing in opportunities from the Life Science and Healthcare sector.

THERAPEUTICS

A highly successful therapeutics industry has emerged in Europe, with experienced entrepreneurs and world-leading scientists. We see ourselves as an active partner in advancing the development and provide crucial support in ultimately  bringing these products to the market.

MEDTECH AND DIAGNOSTICS

Diagnostics are at the forefront of personalized medicine and as such of great interest to us.  We also support interesting projects engaged in the development of new medical technologies.

DIGITAL HEALTH

With the advent of digitaltechnologies in the healthcare sector, a new breed of companies is developing: Digital in nature but tackling medical needs that have so far been addressed by pharma, medtech and medical services.

Other

CARMA FUND is open to all areas from the Life Science and Healthcare. This can include for example R&D tools, platform technologies, improvements to the healthcare system or technologies from the white or green biotech sector.

Contact

Munich

Address

Herzogstr. 64
80803 Munich
Germany

Frankfurt

Address

Altenhöferallee 3
60438 Frankfurt am Main
Germany